Standout Papers

Expression of Epiregulin and Amphiregulin and <i>K-ras</i> Mutation Status Predict Disease Contr... 2007 2026 2013 2019 880
  1. Expression of Epiregulin and Amphiregulin and K-ras Mutation Status Predict Disease Control in Metastatic Colorectal Cancer Patients Treated With Cetuximab (2007)
    Shirin Khambata‐Ford, Christopher R. Garrett et al. Journal of Clinical Oncology
  2. Effect of Dietary Protein and Processing on Gut Microbiota—A Systematic Review (2022)
    Shujian Wu, Hina F. Bhat et al. Nutrients

Immediate Impact

14 by Nobel laureates 20 from Science/Nature 74 standout
Sub-graph 1 of 17

Citing Papers

T-cell-engaging bispecific antibodies in cancer
2023 Standout
A view on drug resistance in cancer
2019 StandoutNature
3 intermediate papers

Works of Shujian Wu being referenced

Safety and preliminary clinical activity of JNJ-63898081 (JNJ-081), a PSMA and CD3 bispecific antibody, for the treatment of metastatic castrate-resistant prostate cancer (mCRPC).
2022
Expression of Epiregulin and Amphiregulin and K-ras Mutation Status Predict Disease Control in Metastatic Colorectal Cancer Patients Treated With Cetuximab
2007 Standout

Author Peers

Author Last Decade Papers Cites
Shujian Wu 1106 1002 429 45 2.5k
Gopalakrishnan Ramakrishnan 1508 429 218 61 2.8k
Evi Schmid 1386 412 337 74 3.0k
Samuel Asfaha 938 857 362 50 3.5k
Marjan Garmyn 1168 482 205 97 2.9k
James O’Kelly 1398 468 126 59 3.0k
Britta Walker 1116 384 275 21 2.7k
Shinji Naito 1442 632 276 60 3.4k
Patrick Münzer 1345 417 330 51 3.3k
Eric A.G. Blomme 1167 500 284 76 3.2k
Aurelia Lugea 1140 1717 165 79 4.2k

All Works

Loading papers...

Rankless by CCL
2026